close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
The Under-the-Radar Stock Big Money Is Quietly Buying Up ↗
Via The Motley Fool
Topics Artificial Intelligence Product Recall
Tickers BYDDY F RACE RIVN STLA TSLA
Exposures Artificial Intelligence Legal Product Safety
News headline image
Kaplan Fox Notifies Investors of Medline Inc. (NASDAQ: MDLN) of an Investigation Into Potential Securities Law Violations
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on November 3, 2026 Against Beta Bionics, Inc. (NASDAQ: BBNX)
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (NASDAQ: FULC) on Behalf of Investors
Via NewMediaWire
Tickers FULC
Exposures Product Safety
News headline image
Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm Before Lead Plaintiff Deadline on September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
How This Gene Therapy Name Partially Reversed Its Catastrophic 44% Dive ↗
Via Investor's Business Daily
Exposures Product Safety
News headline image
Should You Buy Medtronic Stock as Its Hugo Surgical Robot Gains Ground? ↗
Via The Motley Fool
Topics Artificial Intelligence
Tickers ARM ISRG MDT NVDA
Exposures Artificial Intelligence Product Safety
MissionIRNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Positions SSi Mantra Amidst Expanding MedTech Market
Via Investor Brand Network
Tickers SSII
Exposures Product Safety
News headline image
WhiteSands Treatment Publishes New Drug Detox Resource as Updated Clinical Guidance Sharpens Focus on Withdrawal Safety
Via Press Advantage
Exposures Product Safety
News headline image
Aldo Vidinha on FDA QMSR Compliance: Why an ISO 13485 Certificate Is Not Proof ↗
Via Talk Markets
Exposures Product Safety
News headline image
Kaplan Fox Continues to Alert Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Class Action Deadline on November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Reminds Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Securities Class Action Deadline - Contact the Firm Before September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
How to Get Diazepam (Valium) 10mg Legitimately With a Prescription ↗
Via Talk Markets
Exposures Product Safety
News headline image
OS Therapies Achieves Incremental Alignment With FDA and Accepts Project Orbis Invitation From MHRA on OST-HER2 Metastatic Osteosarcoma Program
Via Newsfile
Tickers OSTX
Exposures Product Safety
News headline image
Ispire (ISPR) Q4 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Cannabis Earnings
Tickers ISPR
Exposures Cannabis Financial Product Safety
News headline image
Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors Seeking Recovery to Contact the Firm Before November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
Creative Biolabs Expands In Vitro ADME Support for Early Drug Discovery
Via Get News
Exposures Product Safety
News headline image
Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm to Learn About Their Legal Rights
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Reminds Investors of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) to a Securities Class Action Deadline - Contact the Firm Before November 2, 2026
Via NewMediaWire
Topics Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
SS Innovations International Inc. (NASDAQ: SSII) Expands Global Footprint as SSi Mantra Procedures Reach 14,103
Via Investor Brand Network
Tickers SSII
Exposures Product Safety
News headline image
Geron Eyes High End of 2026 RYTELO Revenue Guidance as Community Adoption Expands ↗
Via MarketBeat
Tickers GERN
Exposures Product Safety
News headline image
cGMP vs Non-GMP Peptides: What Researchers Should Know ↗
Via Talk Markets
Topics Supply Chain
Exposures Product Safety Supply Chain
News headline image
From Uncertainty to Reassurance: How a Small Heart Monitor and Ablation Procedure Helped One Father Conquer the Unknowns of Atrial Fibrillation
Via NewsUSA
Topics Product Recall
Tickers MDT
Exposures Legal Product Safety
News headline image
Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
Kaplan Fox Advises Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) of an Investigation Into Potential Securities Law Violations
Via NewMediaWire
Tickers FULC
Exposures Product Safety
News headline image
FOLIKL Men's Hair Longevity Formula Earns Certification from NSF
Via GetFeatured
Exposures Product Safety
News headline image
Kaplan Fox Alerts Investors to an Upcoming Deadline of September 28, 2026 in the Capricor Therapeutics, Inc. (NASDAQ: CAPR) Securities Class Action
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Robbins LLP is Investigating Allegations that Unicycive Therapeutics, Inc. Failed to Properly Inspect its Third-Party Vendor's Manufacturing Facility to Ensure it Resolved the FDA's Previously Noted Deficiencies
Via Newsfile
Topics Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
News headline image
Altus Clinical Research Reports Multimillion-Dollar Growth and a Clean FDA Inspection Record
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to the Lead Plaintiff Deadline on September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.